Geode Capital Management
CINC

Geode Capital Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Geode Capital Management’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-420,310
Closed -$5.17M – 4895
2022
Q4 		$5.17M Buy
420,310
+65,177
+18% +$1.55M ﹤0.01% 2653
2022
Q3 		$11.7M Buy
355,133
+124,591
+54% +$3.52M ﹤0.01% 2121
2022
Q2 		$4.34M Buy
230,542
+21,644
+10% +$414K ﹤0.01% 2785
2022
Q1 		$3.66M Buy
+208,898
New +$4.29M ﹤0.01% 2962

Geode Capital Management's CINC Position: Q1 2023 in Review

Geode Capital Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 420,310 shares — an estimated $5.17M sold.

Geode Capital Management first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $11.7M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Geode Capital Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Geode Capital Management sold 420,310 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $5.17M.
  • Geode Capital Management first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Geode Capital Management's CinCor Pharma, Inc. Common Stock position peaked at $11.7M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.